Skip to main content

Milestone 9.H

Launch research programs to develop and validate sensitive neuropsychological and behavioral assessment measures to detect and track the earliest clinical manifestations of AD and related dementias.

Success Criteria

Development of at least one sensitive neuropsychological assessment measure that has been validated for the detection or tracking of the earliest clinical manifestations of AD and related dementias.

Time Required

2014 to 2018

Research Implementation Area

Biomarkers

CADRO Category

B. Diagnosis, Assessment and Disease Monitoring

Funded Research Projects

IADRP – Category B. Diagnosis, Assessment and Disease Monitoring - 3. Cognitive…
NIH PAR-15-359: Novel Approaches to Diagnosing Alzheimer's Disease & Predicting…
NIH RFA-AG-17-052: Alzheimer's Disease Outcomes Research Resource (U2C)
NIH PA-16-091: Small Business Alzheimer's Disease Research (R43/R44)
NIH PA-16-092: Small Business Alzheimer's Disease Research (R41/R42)
NIH RFA-AG-17-052: Alzheimer's Disease Outcomes Research Resource (U2C)
NIH PAR-18-183: T1 Translational Research on Aging: Small Business Innovation A…
NIH PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-…
NIH PAR-18-519: Sensory and motor system changes as predictors of preclinical A…